Browsing by Author Vynnychenko, Ihor Oleksandrovych


Showing results 1 to 20 of 50
Issue Year Title Author(s) Type Views Downloads
2022 Atezolizumab (atezo) vs best supportive care (BSC) in stage II-IIIA NSCLC with high PD-L1 expression: Sub-analysis from the pivotal phase III IMpower010 study Felip, E.; Altorki, N.K.; Zhou, C.; Vallieres, E.; Vynnychenko, Ihor Oleksandrovych; Akopov, A.; Martinez-Marti, A.; Chella, A.; Bondarenko, I.; Ursol, G.; Levchenko, E.; Kislov, N.; Liersch, R.; Belleli, R.; McNally, V.A.; Bennett, E.; Gitlitz, B.J.; Wakelee, H. Conference Papers 4009127 5569260
2020 Atezolizumab in Combination With Carboplatin and Nab-Paclitaxel in Advanced Squamous NSCLC (IMpower131): Results From a Randomized Phase III Trial Jotte, Robert; Cappuzzo, Federico; Vynnychenko, Ihor Oleksandrovych; Stroyakovskiy, Daniil; Rodríguez-Abreu, Delvys; Hussein, Maen; Soo, Ross; Conter, Henry J.; Kozuki, Toshiyuki; Huang, Kuan-Chieh; Graupner, Vilma; Sun, Shawn W.; Hoang, Tien; Jessop, Helen; McCleland, Mark; Ballinger, Marcus; Sandler, Alan; Socinski, Mark A. Article 11343391 14935438
2021 Correlation between week 24 trastuzumab-dkst response and week 48 progression-free survival: the HERITAGE trial Rugo, Hope S.; Pennella, Eduardo J.; Gopalakrishnan, Unmesh; Hernandez-Bronchud, M.; Herson, Jay; Koch, Hans Friedrich; Loganathan, Subramanian; Deodhar, Sarika; Marwah, Ashwani; Manikhas, Alexey; Bondarenko, Igor; Parra, Joseph D.; Abesamis-Tiambeng, Maria Luisa T.; Akewanlop, Charuwan; Vynnychenko, Ihor Oleksandrovych; Sriuranpong, Virote; Roy, Sirshendu; Yanez Ruiz, Eduardo Patricio; Barve, Abhijit; Waller, Cornelius F Article -420076701 -1800398028
2020 Durvalumab with or without tremelimumab in patients with recurrent or metastatic head and neck squamous cell carcinoma: EAGLE, a randomized, open-label phase III study Ferris, R.L.; Haddad, R.; Even, C.; Tahara, M.; Dvorkin, M.; Ciuleanu, T.E.; Clement, P.M.; Mesia, R.; Kutukova, S.; Zholudeva, L.; Daste, A.; Caballero-Daroqui, J.; Keam, B.; Vynnychenko, Ihor Oleksandrovych; Lafond, C.; Shetty, J.; Mann, H.; Fan, J.; Wildsmith, S.; Morsli, N.; Fayette, J.; Licitra, L. Article 66645641 63330896
2023 Durvalumab with or without tremelimumab versus the EXTREME regimen as first-line treatment for recurrent or metastatic squamous cell carcinoma of the head and neck: KESTREL, a randomized, open-label, phase III study Psyrri, A.; Fayette, J. Vynnychenko; Harrington, K.; Gillison, M.; Ahn, M.-J.; Takahashi, S.; Weiss, J.; Machiels, J.-P.; Baxi, S.; Vasilyev, A.; Karpenko, A.; Dvorkin, M.; Hsieh, C.-Y.; Thungappa, S.C.; Segura, P.P.; Vynnychenko, Ihor Oleksandrovych; Haddad, R.; Kasper, S.; Mauz, P.-S.; Baker, V.; He, P.; Evans, B.; Wildsmith, S.; Olsson, R.F.; Yovine, A.; Kurland, J.F.; Morsli, N.; Seiwert, T.Y. Article 28 25
2022 Evaluating Alternative Ramucirumab Doses as a Single Agent or with Paclitaxel in Second-Line Treatment of Locally Advanced or Metastatic Gastric/Gastroesophageal Junction Adenocarcinoma: Results from Two Randomized, Open-Label, Phase II Studies Shah, M.A.; Udrea, A.A.; Bondarenko, I.; Mansoor, W.; Sánchez, R.G.; Sarosiek, T.; Bozzarelli, S.; Schenker, M.; Gomez-Martin, C.; Morgan, C.; Özgüroğlu, M.; Pikiel, J.; Kalofonos, H.P.; Wojcik, E.; Buchler, T.; Swinson, D.; Cicin, I.; Joseph, M.; Vynnychenko, Ihor Oleksandrovych; Luft, A.V.; Enzinger, P.C.; Salek, T.; Papandreou, C.; Tournigand, C.; Maiello, E.; Wei, R.; Ferry, D.; Gao, L.; Oliveira, J.M.; Ajani, J.A. Article 413609 56480
2021 FAST: a randomised phase II study of zolbetuximab (IMAB362) plus EOX versus EOX alone for first-line treatment of advanced CLDN18.2-positive gastric and gastro-oesophageal adenocarcinoma Sahin, U.; Türeci, Ö.; Manikhas, G.; Lordick, F.; Rusyn, A.; Vynnychenko, Ihor Oleksandrovych; Dudov, A.; Bazin, I.; Bondarenko, I.; Melichar, B.; Dhaene, K.; Wiechen, K.; Huber, C.; Maurus, D.; Arozullah, A.; Park, J. W.; Schuler, M.; Al-Batran, S.-E. Article 1 0
2021 Final overall survival analysis of the phase 3 HERITAGE study demonstrates equivalence of trastuzumab-dkst to trastuzumab in HER2-positive metastatic breast cancer Rugo, H.S.; Pennella, E.J.; Gopalakrishnan, U.; Hernandez‑Bronchud, M.; Herson, J.; Koch, H.F.; Loganathan, S.; Deodhar, S.; Marwah, A.; Manikhas, A.; Bondarenko, I.; Mukhametshina, G.; Nemsadze, G.; Parra, J.D.; Abesamis‑Tiambeng, M.L.T.; Baramidze, K.; Akewanlop, C.; Vynnychenko, Ihor Oleksandrovych; Sriuranpong, V.; Mamillapalli, G.; Roy, S.; Ruiz, E.P.Ya.; Barve, A.; Fuentes‑Alburo, A.; Walle, C.F. Article 0 0
2024 Inflammatory markers as predictors of efficacy of bevacizumab and tyrosine kinase inhibitors therapy in metastatic non-small cell lung cancer patients Vynnychenko, Ihor Oleksandrovych; Moskalenko, Yuliia Vasylivna Article 0 0
2023 KEYNOTE-033: Randomized phase 3 study of pembrolizumab vs docetaxel in previously treated, PD-L1-positive, advanced NSCLC Ren, S.; Feng, J.; Ma, S.; Chen, H.; Ma, Z.; Huang, C.; Zhang, L.; He, J.; Wang, C.; Zhou, J.; Danchaivijitr, P.; Wang, C.-C.; Vynnychenko, Ihor Oleksandrovych; Wang, K.; Orlandi, F.; Sriuranpong, V.; Li, B.; Ge, J.; Dang, T.; Zhou, C. Article 1794 796
2017 Laryngeal cancer: modern approaches Kurochkin, Andrii Viktorovych; Vynnychenko, Ihor Oleksandrovych; Олісеєнко, Денис Вікторович; Олисеенко, Денис Викторович; Oliseienko, Denys Viktorovych Conference Papers 16957709 9597721
2021 Modern vector in treatment of patients with lung cancer: tyrosine kinase inhibitors in epidermal growth factor receptor mutations (literature review) Smorodska, Olha Mykolaivna; Moskalenko, Yuliia Vasylivna; Vynnychenko, Ihor Oleksandrovych; Vynnychenko, Oleksandr Ihorovych; Kostiuchenko, Vitaliia Viktorivna Article 1879178873 2070660032
2023 NEPTUNE: Phase 3 Study of First-Line Durvalumab Plus Tremelimumab in Patients With Metastatic NSCLC de Castro, Gilberto Jr.; Rizvi, Naiyer A.; Schmid, Peter; Syrigos, Konstantinos; Martín, Claudio; Yamamoto, Nobuyuki; Cheng, Ying; Moiseyenko, Vladimir; Summers, Yvonne; Vynnychenko, Ihor Oleksandrovych; Lee, Sung Yong; Bryl, Maciej; Zer, Alona; Erman, Mustafa; Timcheva, Constanta; Raja, Rajiv; Naicker, Kirsha; Scheuring, Urban; Walker, Jill; Mann, Helen; Chand, Vikram; Mok, Tony Article 637 680
2020 PIK3CA-mutant circulating tumor DNA in patients with breast cancer Vynnychenko, Ihor Oleksandrovych; Pryvalova, Anastasiia Oleksandrivna; Vynnychenko, Oleksandr Ihorovych; Lyndin, Mykola Serhiiovych; Sikora, Vladyslav Volodymyrovych; Romaniuk, Anatolii Mykolaiovych Article -51041384 2142914227
2020 Randomized, open-label phase III study of pembrolizumab (pembro) vs docetaxel (doce) in patients (pts) with previously treated NSCLC with PD-L1 tumour proportion score (TPS) ≥1%: KEYNOTE-033 Zhou, C.; Feng, S.; Ma, S.; Chen, H.; Ma, Z.; Huang, C.; Zhang, L.; He, J.; Wang, C.; Zhou, J.; Danchaivijtr, P.; Huang, H-C.; Vynnychenko, Ihor Oleksandrovych; Wang, K.; Orlandi, F.; Sriuranpong, V.; Li, B.; Ge, J.; Dang, T. Conference Papers 1963732892 112788198
2021 Subsequent therapy following pembrolizumab + axitinib or sunitinib treatment for advanced renal cell carcinoma (RCC) in the phase III KEYNOTE-426 study Gafanov, R.; Powles, T.B.; Bedke, J.; Stus, V.; Waddell, T.S.; Nosov, D.; Pouliot, F.; Soulieres, D.; Melichar, B.; Azevedo, S.; McDermott, R.S.; Vynnychenko, Ihor Oleksandrovych; Borchiellini, D.; Markus, M.; Bondarenko, I.; Lin, J.; Burgents, J.; Molife, L.R.; Plimack, E.R.; Rini, B. Conference Papers 13882134 17079006
2019 The effect of prostatic stones on the immunophenotype of prostate cancer cells Piddubnyi, Artem Mykhailovych; Lyndin, Mykola Serhiiovych; Moskalenko, Yuliia Vasylivna; Vynnychenko, Ihor Oleksandrovych; Romaniuk, Anatolii Mykolaiovych; Moskalenko, Roman Andriiovych Conference Papers -606339310 -2114626701
2018 TNM Classification of Malignant Tumours with Test Questions (Seventh Edition, 2009) Moskalenko, Yuliia Vasylivna; Vynnychenko, Ihor Oleksandrovych; Vynnychenko, Oleksandr Ihorovych Book 97326875 94496782
2022 Toluidine blue for the detection of sentinel lymph nodes in patients with thyroid cancer Moskalenko, Yuliia Vasylivna; Kurochkin, Andrii Viktorovych; Vynnychenko, Ihor Oleksandrovych; Kravets, Oleksandr Valeriiovych; Piddubnyi, Artem Mykhailovych; Moskalenko, Roman Andriiovych; Potapov, Oleksandr Oleksandrovych Article 106 27
2022 Toluidine blue for the detection of sentinel lymph nodes in patients with thyroid cancer Moskalenko, Yuliia Vasylivna; Kurochkin, Andrii Viktorovych; Vynnychenko, Ihor Oleksandrovych; Kravets, Oleksandr Valeriiovych; Piddubnyi, Artem Mykhailovych; Moskalenko, Roman Andriiovych; Potapov, Oleksandr Oleksandrovych Article 1 0